Dynavax Technologies Corp

NASDAQ: DVAX
$3.87
-$0.06 (-1.5%)
Closing price October 27, 2020
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting...
The top analyst upgrades, downgrades and other research calls from Thursday include Andeavor, Cimarex Energy, Groupon, Macy's, Marathon Petroleum, Match Group and Republic Services.
Dynavax Technologies saw its shares make a handy gain early on Wednesday after the company announced that it received a recommendation from the CDC's Advisory Committee on Immunization Practices.
The top analyst upgrades, downgrades and other research calls from Monday include Apple, BHP Billiton, CBS, Eli Lilly, GE, Halliburton, IBM, Schlumberger and Verizon.
A new RBC report is reasonably positive on the biotech sector for the coming year. These eight top picks for 2018 all have the potential for big upside moves.
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Now that the U.S. presidential election is over and markets have recovered to their highs, there are still some stocks holding back the markets from breaking even higher.
November 14, 2016: Here are four stocks trading with relatively heavy volume among 75 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by less than 100...
Dynavax Technologies Corp. (NASDAQ: DVAX) shares  crumbled Monday morning after the company said that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA)....
September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Friday’s session. NYSE advancers led decliners by nearly 4 to 1 and...
24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.
March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday’s session. Unisys Corp. (NYSE: UIS) fell by nearly 28% on Wednesday to post...